Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Quotient Clinical at AAPS 2013

Published: Friday, November 08, 2013
Last Updated: Friday, November 08, 2013
Bookmark and Share
AAPS annual meeting and exposition to be held in San Antonio, Texas, from the 10th to the 14th of November.

Quotient Clinical will be showcasing the benefits of its unique, integrated approach to formulation development, real-time manufacturing and clinical testing on booth 2800 at this year’s American Association of Pharmaceutical Scientists (AAPS) Annual Meeting and Exposition.

Held in San Antonio, Texas, from the 10th to the 14th of November, this meeting will provide delegates with the opportunity to see some of the latest developments in the pharmaceutical sector, including a variety of projects which have benefitted from the reduced costs and faster time-to-market offered by Quotient Clinical’s innovative development platform.

Quotient Clinical will be supporting several other activities and events at the meeting, including a RapidFACT™ user group meeting and six poster presentations.

The RapidFACT user meeting will aim to build on last year’s highly successful event, and will include a number of customer presentations, as well as an open forum to discuss various aspects of the RapidFACT process.

On the final day of the conference, Dr Alyson Connor, Director of Exploratory Clinical Pharmacology at Quotient Clinical, will be participating in a symposium featuring a number of prominent speakers from academia and industry entitled Understanding in vivo dissolution: can imaging tools provide the missing link?

Alyson will be discussing the practicalities of tracking oral dosage form performance using scintigraphic imaging, and participating in a panel discussion on the use of imaging tools in pharmaceutical research.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More Than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Quotient Clinical Begins Prostate Cancer Project for Druggability Technologies
The program will assess new formulations using DRGT’s proprietary Super-API technology, and aims to reduce dose and address food effects associated with the drug.
Wednesday, June 24, 2015
Quotient Clinical Completes Innovative First-In-Human Program
First-in-human clinical program designed to develop an optimal oral formulation.
Thursday, April 23, 2015
Quotient Clinical Announces ADME Success in Oncology
Company to supply 14C radiolabelled drug products to specialist oncology clinics globally.
Thursday, April 02, 2015
Quotient Clinical Showcases ‘Gold Standard’ Human ADME Studies and Applications
Company will present a symposium and three poster publications at ISSX/JSSX 2014.
Wednesday, September 24, 2014
Quotient Clinical Celebrates its 50th RapidFACT™ Program
The 50th Rapid Formulation development And Clinical Testing program marks a significant milestone in the development of this service.
Thursday, February 06, 2014
Quotient Clinical Announces New Investment In Translational Pharmaceutics™
The investment represents a significant expansion of Quotient's capacity and capabilities.
Tuesday, November 19, 2013
Scientific News
The Changing Tides of the In Vitro Diagnostics Market
With the increasing focus in personalized medicine, diagnostics plays a crucial role in patient monitoring.
LaVision BioTec Reports on the Neuro Research on the Human Brain After Trauma
Company reports on the work of Dr Ali Ertürk from the Institute for Stroke and Dementia Research at LMU Munich.
NIH Study Shows No Benefit of Omega-3 Supplements for Cognitive Decline
Research was published in the Journal of the American Medical Association.
Less May Be More in Slowing Cholera Epidemics
Mathematical model shows more cases may be prevented and more lives saved when using one dose of cholera vaccine instead of recommended two doses.
Investigating the Vape
Expert independent review concludes that e-cigarettes have potential to help smokers quit.
NIH Launches Human RSV Study
Study aims to understand infection in healthy adults to aid development of RSV medicines, vaccines.
Researchers Discover Synthesis of a New Nanomaterial
Interdisciplinary team creates biocomposite for first time using physiological conditions.
Poor Survival Rates in Leukemia Linked to Persistent Genetic Mutations
For patients with an often-deadly form of leukemia, new research suggests that lingering cancer-related mutations – detected after initial treatment with chemotherapy – are associated with an increased risk of relapse and poor survival.
Flu Remedies Help Combat E. coli Bacteria
Physiologists from the University of Zurich have now discovered why the intestinal bacterium Escherichia coli (E. coli) multiplies heavily and has an inflammatory effect.
Marijuana Genome Unraveled
A study by Canadian researchers is providing a clearer picture of the evolutionary history and genetic organization of cannabis, a step that could have agricultural, medical and legal implications for this valuable crop.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!